SEARCH

SEARCH BY CITATION

References

  • Brunstein, CG, Setubal, CD & Wagner, JE. (2007) Expanding the role of umbilical cord blood transplantation. British Journal of Haematology, 137, 2035.
  • Brunstein, CG, Cantero, S, Cao, Q, Majhail, N, McClune, B, Burns, LJ, Tomblyn, M, Miller, JS, Blazar, BR, McGlave, PB, Weisdorf, DJ & Wagner, JE. (2009) Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 214222.
  • Delgado, J, Thomson, K, Russell, N, Ewing, J, Stewart, W, Cook, G, Devereux, S, Lovell, R, Chopra, R, Marks, DI, Mackinnon, S & Milligan, DW. (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation study. Blood, 107, 17241730.
  • Dreger, P, Brand, R, Milligan, D, Corradini, P, Finke, J, Lambertenghi Deliliers, G, Martino, R, Russell, N, van Biezen, A, Michallet, M & Niederwieser, D. (2005) Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis. Leukemia, 19, 10291033.
  • Keating, MJ, O’Brien, S, Kontoyiannis, D, Plunkett, W, Koller, C, Beran, M, Lerner, S & Kantarjian, H. (2002) Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leukaemia & Lymphoma, 43, 17551762.
  • Majhail, NS, Brunstein, CG, Tomblyn, M, Thomas, AJ, Miller, JS, Arora, M, Kaufman, DS, Burns, LJ, Slungaard, A, McGlave, PB, Wagner, JE & Weisdorf, DJ. (2008) Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of Blood and Marrow Transplantation, 14, 282289.
  • Rodrigues, CA, Sanz, G, Brunstein, CG, Sanz, J, Wagner, JE, Renaud, M, de Lima, M, Cairo MS, Fürst S, Rio, B, Dalley, C, Carreras, E, Harousseau, JL, Mohty, M, Taveira, D, Dreger, P, Sureda, A, Gluckman, E & Rocha, V. (2009) Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and Lymphoma Working Party for the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 27, 256263.
  • Schetelig, J, Thiede, C, Bornhauser, M, Schwerdtfeger, R, Kiehl, M, Beyer, J, Sayer, HG, Kroger, N, Hensel, M, Scheffold, C, Held, TK, Hoffken, K, Ho, AD, Kienast, J, Neubauer, A, Zander, AR, Fauser, AA, Ehninger, G & Siegert, W. (2003) Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem cell transplantation: the Cooperative German Transplant Study group. Journal of Clinical Oncology, 21, 27472753.
  • Sorror, ML, Marris, MB, Storb, R, Baron, F, Sandmaier, BM, Maloney, DG & Storer, B. (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood, 106, 29122919.
  • Sorror, ML, Storer, B, Sandmaier, B, Maris, M, Shizuru, J, Maziarz, R, Agura, E, Chauncey, TR, Pulsipher, MA, McSweeney, PA, Wade, JC, Bruno, B, Langston, A, Radich, J, Niederwieser, D, Blume, KG, Storb, R & Maloney, DG. (2008) Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after non-myeloablative conditioning. Journal of Clinical Oncology, 26, 49124920.